MedTrace Logo

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

NCT00131053 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2008-11-14

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.

Conditions

  • Lymphoblastic Leukemia, Acute

Interventions

DRUG

Methotrexate

DRUG

Prednisolone

DRUG

Dexamethasone

DRUG

Vincristine

DRUG

Pirarubicin

DRUG

Cyclophosphamide

DRUG

L-asparaginase

DRUG

Cytarabine

DRUG

Hydrocortisone

DRUG

Mercaptopurine

Sponsors & Collaborators

  • Japan Adult Leukemia Study Group

    lead OTHER

Principal Investigators

  • Fumihiko Hayakawa, MD · Nagoya University

  • Tomoki Naoe, MD · Nagoya University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2011-05-31
Completion
2011-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131053 on ClinicalTrials.gov